Sigyn Therapeutics, Inc. (SIGY)
OTCMKTS · Delayed Price · Currency is USD
3.500
0.00 (0.00%)
At close: Sep 17, 2025
Sigyn Therapeutics Market Cap
Sigyn Therapeutics has a market cap or net worth of $6.42 million as of September 17, 2025. Its market cap has decreased by -80.73% in one year.
Market Cap
6.42M
Enterprise Value
8.99M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$3.50
Market Cap Chart
Since October 20, 2020, Sigyn Therapeutics's market cap has decreased from 66.98M to 6.42M, a decrease of -90.41%. That is a compound annual growth rate of -38.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2025 | 6.42M | 26.98% |
| Dec 17, 2024 | 5.06M | -16.78% |
| Dec 27, 2023 | 6.08M | -4.15% |
| Dec 29, 2022 | 6.34M | -66.00% |
| Dec 30, 2021 | 18.65M | -57.38% |
| Dec 31, 2020 | 43.76M | -34.67% |
| Oct 20, 2020 | 66.98M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 792.01M |
| Elite Pharmaceuticals | 718.26M |
| Glass House Brands | 574.70M |
| CytoDyn | 377.06M |
| Northwest Biotherapeutics | 373.88M |
| American Oncology Network | 345.48M |